Stem Cell Therapy Combined Hormone Replacement Therapy in Patients With Premature Ovarian Failure

NCT01742533 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Premature Ovarian Failure，

Interventions

BIOLOGICAL: human umbilical cord mesenchymal stem cells
BIOLOGICAL: hUCMSCs and hCBMNCs
BIOLOGICAL: human cord blood mononuclear cells
DRUG: Hormone Replacement Therapy

Sponsor

Shenzhen Beike Bio-Technology Co., Ltd.